Wilson Sonsini Goodrich & Rosati is the premier legal advisor to technology, life sciences, and other growth enterprises worldwide. We represent companies at every stage of development, from entrepreneurial start-ups to multibillion-dollar global corporations, as well as the venture firms, private equity firms, and investment banks that finance and advise them. The firm’s broad range of services and practice areas are focused on addressing the principal challenges faced by the management, boards of directors, shareholders, and in-house counsel of our clients.
乐博28官网The firm is nationally recognized for providing high-quality services to address the legal solutions required by its enterprise and financial institution clients. Our services include corporate law and governance, public and private offerings of equity and debt securities, mergers and acquisitions, securities class action litigation, intellectual property litigation, antitrust counseling and litigation, joint ventures and strategic alliances, technology licensing and other intellectual property transactions, tax, and employee benefits and employment law, among other areas. Our distinguished international roster of clients span a wide variety of industries, including information technology, life sciences, energy and clean technology, media and entertainment, communications, retail, and financial services.
乐博28官网jefferies provides insight, expertise and execution to investors, companies and government entities. we offer deep sector expertise across a full range of products and services in investment banking, equities, fixed income and wealth management in the americas, europe and the middle east and asia. as one of the largest global healthcare investment banking team, we have more than 100 healthcare bankers worldwide covering over 780 corporate clients. jefferies healthcare team has a strong track record in transacting with chinese healthcare companies in strong cross-border capabilities that connect chinese buyers to healthcare opportunities globally. the team has global execution capabilities and a strong track record across both m&a and equity offerings, including a market leading global biotech franchise. jefferies coverage bankers provide in-depth worldwide coverage of all healthcare subsectors, including biotech, medtech, pharmaceuticals, diagnostics, and healthcare services. managing directors have an average of 17 years of healthcare investment banking experience.
乐博28官网suzhou biobay is the key driver of life science innovation for suzhou industrial park (sip). nearly 500 high-tech innovative companies covering drug discovery, medical device (including ivd), biotech, cro have been located in biobay. more than 10000 scientists and professionals have come to join this dynamic innovative community, including 62 talents of the recruitment program of global experts.
BioBAY is playing an active role in building an interactive and collaborative innovation ecosystem:
- Cold Spring Harbor Asia Conference Centre — cutting-edge academic resources and global technical communication
- BioTOP — one-stop professional solutions for biomedical companies, including analysis & test, GMP verification, biomaterials trading, training, etc.
- BioBAY Sangtian Island — commercialization base for high-tech drug, medical device and IVD companies
- BioBAY Changshu — top class industrial base for biomedical industry with international advanced standards
乐博28官网6 dimensions capital is a leading healthcare focused investment firm with an in-depth focus and extensive coverage across china and the united states. the firm currently has us$1.6 billion assets under management through 4 us dollar-denominated and 3 rmb-denominated funds with offices in shanghai, boston, hong kong and san francisco.
6 dimensions capital was formed in may 2017 through the merger of frontline bioventures and wuxi healthcare ventures, two prominent and complementary china-u.s. healthcare investment firms. the merger has created a powerhouse that aims to fund innovation in an optimal position to capture the biggest value appreciation on both sides of the pacific.
乐博28官网bayhelix group is a non-profit, invitation-only organization of business leaders of chinese heritage that fosters the growth of the life sciences and healthcare industry around the pacific rim and beyond. founded in 2001, bayhelix has grown to over 300 members throughout the u.s., canada, and greater china. the membership base covers virtually all of the world’s top pharmaceutical and biopharmaceutical companies, as well as leading services and investment firms. over one third of the members are senior executives, over 80% have phds in the life sciences, and nearly half have mbas from the leading business schools in u.s.
乐博28官网since its founding in 2007, chinabio® group has created a broad platform of capabilities connecting china life science with the world. chinabio has helped western life science companies identify over 400 licensing and acquisition opportunities and raise over usd 500 million in funding in china.
乐博28官网our mission is simple: create the best, most innovative events to provide you with the latest business information and the greatest opportunity to network with your peers and new potential business partners.
since 2008, lychee group has helped launch some of the longest running and most reputable life sciences conferences in china including: chinatrials: clinical development leaders' summit, china healthcare investment conference (chic), china medical affairs summit, devicechina, biocentury's china healthcare summit and healthcare capital & connections summit (hccs).
founded by industry-recognized editors, rnder and pharmadj are the leading publications providing value-added analysis for pharmaceutical and biotechnology companies doing business in china. with a mission to facilitate drug r&d and regulatory science in china, we talk to regulators and key opinion leaders from industry to piece together the china market puzzle for our readers.